These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10426870)
21. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction. Verheugt FW Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678 [TBL] [Abstract][Full Text] [Related]
22. Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challenges. Smith KM; Mehta JL J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):143-50. PubMed ID: 11150403 [No Abstract] [Full Text] [Related]
23. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194 [TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing. Hobbach HP; Schuster P Z Kardiol; 2003 Mar; 92(3):213-8. PubMed ID: 12658467 [TBL] [Abstract][Full Text] [Related]
25. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality? Zeymer U J Thromb Thrombolysis; 2003 Apr; 15(2):91-7. PubMed ID: 14618075 [No Abstract] [Full Text] [Related]
26. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173 [TBL] [Abstract][Full Text] [Related]
27. Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction. Campbell KR; Cantor W; Sketch M; Ohman EM Am Heart J; 2000 Dec; 140(6 Suppl):S115-24. PubMed ID: 11100005 [No Abstract] [Full Text] [Related]
28. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
33. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Zhao XQ; Théroux P; Snapinn SM; Sax FL Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731 [TBL] [Abstract][Full Text] [Related]
34. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Adgey AA Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518 [TBL] [Abstract][Full Text] [Related]
35. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty]. Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204 [TBL] [Abstract][Full Text] [Related]